ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure
ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure
Not yet recruiting · NCT00610051 · Registry updated 2025-12-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure | End Stage Cardiac Failure; HFrEF - Heart Failure With Reduced Ejection Fraction; NYHF Class III-IV | Not yet recruiting | Phase 3 | 2025-12-15 | NCT00610051 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biopeutics Co., Ltd | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medical University Vienna | Vienna | Austria | 11 |